A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel in Rheumatoid Arthritis and Sjogren's Disease

NCT07048197 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD)

Interventions

BIOLOGICAL: Rapcabtagene autoleucel

Sponsor

Novartis Pharmaceuticals